These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 33244314)
1. ProTECT-Prediction of T-Cell Epitopes for Cancer Therapy. Rao AA; Madejska AA; Pfeil J; Paten B; Salama SR; Haussler D Front Immunol; 2020; 11():483296. PubMed ID: 33244314 [TBL] [Abstract][Full Text] [Related]
2. Population-level distribution and putative immunogenicity of cancer neoepitopes. Wood MA; Paralkar M; Paralkar MP; Nguyen A; Struck AJ; Ellrott K; Margolin A; Nellore A; Thompson RF BMC Cancer; 2018 Apr; 18(1):414. PubMed ID: 29653567 [TBL] [Abstract][Full Text] [Related]
3. NEPdb: A Database of T-Cell Experimentally-Validated Neoantigens and Pan-Cancer Predicted Neoepitopes for Cancer Immunotherapy. Xia J; Bai P; Fan W; Li Q; Li Y; Wang D; Yin L; Zhou Y Front Immunol; 2021; 12():644637. PubMed ID: 33927717 [TBL] [Abstract][Full Text] [Related]
4. Tumor-Infiltrating T Cells From Clear Cell Renal Cell Carcinoma Patients Recognize Neoepitopes Derived From Point and Frameshift Mutations. Hansen UK; Ramskov S; Bjerregaard AM; Borch A; Andersen R; Draghi A; Donia M; Bentzen AK; Marquard AM; Szallasi Z; Eklund AC; Svane IM; Hadrup SR Front Immunol; 2020; 11():373. PubMed ID: 32226429 [TBL] [Abstract][Full Text] [Related]
5. The neoepitope landscape of breast cancer: implications for immunotherapy. Narang P; Chen M; Sharma AA; Anderson KS; Wilson MA BMC Cancer; 2019 Mar; 19(1):200. PubMed ID: 30832597 [TBL] [Abstract][Full Text] [Related]
6. Targeting Neoepitopes to Treat Solid Malignancies: Immunosurgery. de Sousa E; Lérias JR; Beltran A; Paraschoudi G; Condeço C; Kamiki J; António PA; Figueiredo N; Carvalho C; Castillo-Martin M; Wang Z; Ligeiro D; Rao M; Maeurer M Front Immunol; 2021; 12():592031. PubMed ID: 34335558 [TBL] [Abstract][Full Text] [Related]
7. Seq2Neo: A Comprehensive Pipeline for Cancer Neoantigen Immunogenicity Prediction. Diao K; Chen J; Wu T; Wang X; Wang G; Sun X; Zhao X; Wu C; Wang J; Yao H; Gerarduzzi C; Liu XS Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36232923 [TBL] [Abstract][Full Text] [Related]
8. A Recurrent Mutation in Anaplastic Lymphoma Kinase with Distinct Neoepitope Conformations. Toor JS; Rao AA; McShan AC; Yarmarkovich M; Nerli S; Yamaguchi K; Madejska AA; Nguyen S; Tripathi S; Maris JM; Salama SR; Haussler D; Sgourakis NG Front Immunol; 2018; 9():99. PubMed ID: 29441070 [TBL] [Abstract][Full Text] [Related]
9. Recent Advances in Lung Cancer Immunotherapy: Input of T-Cell Epitopes Associated With Impaired Peptide Processing. Leclerc M; Mezquita L; Guillebot De Nerville G; Tihy I; Malenica I; Chouaib S; Mami-Chouaib F Front Immunol; 2019; 10():1505. PubMed ID: 31333652 [TBL] [Abstract][Full Text] [Related]
11. The Cancer Epitope Database and Analysis Resource: A Blueprint for the Establishment of a New Bioinformatics Resource for Use by the Cancer Immunology Community. Koşaloğlu-Yalçın Z; Blazeska N; Carter H; Nielsen M; Cohen E; Kufe D; Conejo-Garcia J; Robbins P; Schoenberger SP; Peters B; Sette A Front Immunol; 2021; 12():735609. PubMed ID: 34504503 [TBL] [Abstract][Full Text] [Related]
12. The neoepitope landscape in pediatric cancers. Chang TC; Carter RA; Li Y; Li Y; Wang H; Edmonson MN; Chen X; Arnold P; Geiger TL; Wu G; Peng J; Dyer M; Downing JR; Green DR; Thomas PG; Zhang J Genome Med; 2017 Aug; 9(1):78. PubMed ID: 28854978 [TBL] [Abstract][Full Text] [Related]
13. Neoepitopes as cancer immunotherapy targets: key challenges and opportunities. Brennick CA; George MM; Corwin WL; Srivastava PK; Ebrahimi-Nik H Immunotherapy; 2017 Mar; 9(4):361-371. PubMed ID: 28303769 [TBL] [Abstract][Full Text] [Related]
14. TANTIGEN 2.0: a knowledge base of tumor T cell antigens and epitopes. Zhang G; Chitkushev L; Olsen LR; Keskin DB; Brusic V BMC Bioinformatics; 2021 Apr; 22(Suppl 8):40. PubMed ID: 33849445 [TBL] [Abstract][Full Text] [Related]
15. DeepHLApan: A Deep Learning Approach for Neoantigen Prediction Considering Both HLA-Peptide Binding and Immunogenicity. Wu J; Wang W; Zhang J; Zhou B; Zhao W; Su Z; Gu X; Wu J; Zhou Z; Chen S Front Immunol; 2019; 10():2559. PubMed ID: 31736974 [TBL] [Abstract][Full Text] [Related]
16. nextNEOpi: a comprehensive pipeline for computational neoantigen prediction. Rieder D; Fotakis G; Ausserhofer M; René G; Paster W; Trajanoski Z; Finotello F Bioinformatics; 2022 Jan; 38(4):1131-1132. PubMed ID: 34788790 [TBL] [Abstract][Full Text] [Related]
17. Isolation of T cell receptors targeting recurrent neoantigens in hematological malignancies. Tubb VM; Schrikkema DS; Croft NP; Purcell AW; Linnemann C; Freriks MR; Chen F; Long HM; Lee SP; Bendle GM J Immunother Cancer; 2018 Jul; 6(1):70. PubMed ID: 30001747 [TBL] [Abstract][Full Text] [Related]
18. HLA-binding properties of tumor neoepitopes in humans. Fritsch EF; Rajasagi M; Ott PA; Brusic V; Hacohen N; Wu CJ Cancer Immunol Res; 2014 Jun; 2(6):522-9. PubMed ID: 24894089 [TBL] [Abstract][Full Text] [Related]
19. Combination therapies utilizing neoepitope-targeted vaccines. Lee KL; Schlom J; Hamilton DH Cancer Immunol Immunother; 2021 Apr; 70(4):875-885. PubMed ID: 33033852 [TBL] [Abstract][Full Text] [Related]
20. Eradication of Large Solid Tumors by Gene Therapy with a T-Cell Receptor Targeting a Single Cancer-Specific Point Mutation. Leisegang M; Engels B; Schreiber K; Yew PY; Kiyotani K; Idel C; Arina A; Duraiswamy J; Weichselbaum RR; Uckert W; Nakamura Y; Schreiber H Clin Cancer Res; 2016 Jun; 22(11):2734-43. PubMed ID: 26667491 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]